Eric Juengst
Biographic Data
| ID | 6071889 |
|---|---|
| NAME | Eric Juengst |
| GIVEN NAMES | Eric |
| FAMILY NAME | Juengst |
| SIGNATURE | JUENGST E |
| AFFILIATIONS | David L. Rosen is with the Division of Infectious Diseases, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill. Mara Buchbinder, Eric Juengst, and Stuart Rennie are with the Department of Social Medicine, Center for Bioethics, School of Medicine, University of North Carolina at Chapel Hill. |
| VERIFIED | No |
| TOTAL WORKS | 8 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 8 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 1988 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Preventive Human Genome Editing and Enhancement
While somatic cell editing to treat disease is widely accepted, the use of human genome editing for “enhancement” remains contested. Scientists and policy‐makers routinely cite the prospect of enhancement as a salient ethical challenge for human genome editing research. If preventive genome editing projects are perceived as pursuing human enhancement, they could face heightened barriers to scientific, public, and regulatory approval. This article…
Expert stakeholders’ perspectives on a Data-to-Care strategy for improving care among HIV-positive individuals incarcerated in jails
Data-to-Care (D2C) uses surveillance data (e.g., laboratory, Medicaid billing) to identify out-of-care HIV-positive persons to re-link them to care. Most US states are implementing D2C, yet few studies have explored stakeholders' perspectives on D2C, and none have addressed these perspectives in the context of D2C in jail. This article reports findings from qualitative, semi-structured interviews conducted with expert stakeholders regarding their…
Public Health Research, Practice, and Ethics for Justice-Involved Persons in the Big Data Era
Genomic Essentialism
Since the inception of large‐scale human genome research, there has been much caution about the risks of exacerbating a number of socially dangerous attitudes linked to human genetics. These attitudes are usually labeled with one of a family of genetic or genomic “isms” or “ations” such as “genetic essentialism,” “genetic determinism,” “genetic reductionism,” “geneticization,” “genetic stigmatization,” and “genetic discrimination.” The psychosoci…
Are Parents Really Obligated to Learn as Much as Possible about Their Children's Genomes
As new parents quickly learn, parenting always involves choosing your battles. Ideally, parents have the freedom to make those moral choices without the prejudice of an unreasonable or premature inflicted ought. Resolving the predictive uncertainties of genomic information is the professional responsibility of the biomedical community, just as clarifying the impact of global warming or assessing the risks of rising multidrug resistance is the res…
From “Personalized” to “Precision” Medicine
Since the late 1980s, the human genetics and genomics research community has been promising to usher in a “new paradigm for health care”—one that uses molecular profiling to identify human genetic variants implicated in multifactorial health risks. After the completion of the Human Genome Project in 2003, a wide range of stakeholders became committed to this “paradigm shift,” creating a confluence of investment, advocacy, and enthusiasm that bear…
Enhancing Cognition in the Intellectually Intact
As science learns more about how the brain works, and fails to work, the possibility for developing "cognition enhancers" becomes more plausible. And the demand for drugs that can help us think faster, remember more, and focus more keenly has already been demonstrated by the market success of drugs like Ritalin, which tames the attention span, and Prozac, which ups the competitive edge. The new drug Aricept, which improves memory, most likely wil…
Subtracting Injury from Insult
The emergence of implantable drug delivery systems will allow us to\nproduce the effects of psychosurgery and surgical sterilization without their\nirreversible invasions of bodily integrity. However, this clinical advantage\ndoes not resolve the most important ethical problems these surgeries face, and\nmay even obscure them when they arise in the practice of drug\nimplantation
No prominent works on this page.
Subtracting Injury from Insult
The emergence of implantable drug delivery systems will allow us to\nproduce the effects of psychosurgery and surgical sterilization without their\nirreversible invasions of bodily integrity. However, this clinical advantage\ndoes not resolve the most important ethical problems these surgeries face, and\nmay even obscure them when they arise in the practice of drug\nimplantation
Enhancing Cognition in the Intellectually Intact
As science learns more about how the brain works, and fails to work, the possibility for developing "cognition enhancers" becomes more plausible. And the demand for drugs that can help us think faster, remember more, and focus more keenly has already been demonstrated by the market success of drugs like Ritalin, which tames the attention span, and Prozac, which ups the competitive edge. The new drug Aricept, which improves memory, most likely wil…
From “Personalized” to “Precision” Medicine
Since the late 1980s, the human genetics and genomics research community has been promising to usher in a “new paradigm for health care”—one that uses molecular profiling to identify human genetic variants implicated in multifactorial health risks. After the completion of the Human Genome Project in 2003, a wide range of stakeholders became committed to this “paradigm shift,” creating a confluence of investment, advocacy, and enthusiasm that bear…
Are Parents Really Obligated to Learn as Much as Possible about Their Children's Genomes
As new parents quickly learn, parenting always involves choosing your battles. Ideally, parents have the freedom to make those moral choices without the prejudice of an unreasonable or premature inflicted ought. Resolving the predictive uncertainties of genomic information is the professional responsibility of the biomedical community, just as clarifying the impact of global warming or assessing the risks of rising multidrug resistance is the res…
Genomic Essentialism
Since the inception of large‐scale human genome research, there has been much caution about the risks of exacerbating a number of socially dangerous attitudes linked to human genetics. These attitudes are usually labeled with one of a family of genetic or genomic “isms” or “ations” such as “genetic essentialism,” “genetic determinism,” “genetic reductionism,” “geneticization,” “genetic stigmatization,” and “genetic discrimination.” The psychosoci…
Expert stakeholders’ perspectives on a Data-to-Care strategy for improving care among HIV-positive individuals incarcerated in jails
Data-to-Care (D2C) uses surveillance data (e.g., laboratory, Medicaid billing) to identify out-of-care HIV-positive persons to re-link them to care. Most US states are implementing D2C, yet few studies have explored stakeholders' perspectives on D2C, and none have addressed these perspectives in the context of D2C in jail. This article reports findings from qualitative, semi-structured interviews conducted with expert stakeholders regarding their…
Public Health Research, Practice, and Ethics for Justice-Involved Persons in the Big Data Era
Preventive Human Genome Editing and Enhancement
While somatic cell editing to treat disease is widely accepted, the use of human genome editing for “enhancement” remains contested. Scientists and policy‐makers routinely cite the prospect of enhancement as a salient ethical challenge for human genome editing research. If preventive genome editing projects are perceived as pursuing human enhancement, they could face heightened barriers to scientific, public, and regulatory approval. This article…
Political science (5 works) · Law (4 works) · Psychology (4 works) · Biology (3 works) · BRCA gene mutations in cancer (3 works) · Medicine (3 works) · Public relations (3 works) · Bioinformatics (2 works) · Biomedical Ethics and Regulation (2 works) · Biomedicine (2 works)